SCIMEDX CORPORATION, USA is a highly flexible diagnostic company, with
over 35 years’ experience in the area of IN Vitro Diagnostics (IVD).
The
strength of the organization is the collective diversified experiences of the
personnel in many areas of diagnostics and biochemistry. We specialize in
immunofluorescence, ELISA and membrane technologies for a variety of unique and
routine autoimmune and infectious diseases, whereas the Scimedx combines
product development, manufacturing and with a keen awareness of laboratory’s
needs.
SCIMEDX
is confident in its ability to produce first-rate products for the medical
device. Therefore, Scimedx extends its platforms for disease testing:
• The
first was ImmuoCyt an FDA cleared & patented assay for bladder cancer.
• Scimedx
expanded its IFA and Latex Infectious assays by acquiring PANBIO for HHV,
Dengue, West Nile.
• Scimedx
then went on to acquire Parasitology serology assays from IVD Research and
Continuing for growth, Scimedx has finalized its rapid testing platform.
• Scimedx
is the de-facto manufacturer of IFA, ELISA, Agglutination tests, delivering
solutions for disease testing worldwide.
Certificates: ISO 9001, ISO13485, GMP-Certificate, FDA Registration and CE
Mark.